9D4X の概要
エントリーDOI | 10.2210/pdb9d4x/pdb |
分子名称 | Serine/threonine-protein kinase PAK 1, N~2~-{[(1R,3R,4S)-4-amino-3-(3-chlorophenyl)cyclohexyl]methyl}-N~4~-(5-cyclopropyl-1,3-thiazol-2-yl)pyrimidine-2,4-diamine (3 entities in total) |
機能のキーワード | serine/threonine-protein kinase, transferase, inhibitor |
由来する生物種 | Homo sapiens (human) |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 67308.42 |
構造登録者 | |
主引用文献 | Johns, D.M.,Olejniczak, J.,Babbar, A.,Boone, C.D.,Cakici, O.,Cheng, M.,Cheng, Q.Q.,Dementiev, A.,Eick, M.,Ferdyan, N.,Fontano, E.,Forman, A.,Kozlowski, R.,Lee, S.W.,Mehta, S.,Mowery, K.,Murray, B.,Nguyen, V.,Olland, A.,Phan, K.,Rivera, L.,Sabat, M.,Sprengeler, P.,Srinivasan, K.,Sun, Z.,Suto, R.K.,Wilkinson, T.,Wang, C.,Yu, N.,Xu, M.,Goel, V.,Hirst, G.,Reich, S. Identification of a p21-activated kinase 1 (PAK1) inhibitor with 10-fold selectivity against PAK2. Bioorg.Med.Chem.Lett., :130307-130307, 2025 Cited by PubMed Abstract: The p21-activated kinases (PAKs) are noted for their role in cytoskeletal organization, cellular morphogenesis, and pro-survival signaling. PAK1 is of particular interest due to its role in tumorigenesis, being amplified in multiple cancers (the most prevalent being breast, ovarian, and melanoma cancers). PAK2 is closely related to PAK1 in structure but is associated with cardiotoxicity. A structure-based design effort targeting a PAK1 (over PAK2) selective small molecule inhibitor is detailed herein. We report here the first crystal structure of PAK2 and use this crystal structure to design a PAK1 inhibitor with ten-fold selectivity over PAK2. PubMed: 40516764DOI: 10.1016/j.bmcl.2025.130307 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.847 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
